We are doing a study to see if a new treatment, called INO-3107, can help people with recurrent respiratory papillomatosis (RRP). We want to find out if this treatment works well and if it helps patients need fewer surgeries in the future.

Do you have advanced Stage III or IV Head and Neck Cancer? You might be able to join a research study. We are looking at new treatments compared to the usual care for your type of cancer.

Do you have Idiopathic Pulmonary Fibrosis (IPF)? You might be able to try a new pill called Ifetroban. We want to see if this medication can help with your symptoms and stop your lungs from getting worse. Compensation provided.

To identify gaps in services and/or barriers to diagnosis and care for patients with tick-borne illnesses living in NC.

Do you have incurable, metastatic head and neck squamous cell carcinoma ? If so, you may be able to take part in a study to see if a new drug called Cisplatin is effective.

The purpose of this study is to determine if an investigational treatment can address the underlying cause of Graves' disease, and potentially normalize thyroid hormone levels.

We are creating a new way to understand online sexual harassment. As technology changes, people find new ways to harm others online. Current tools don't catch all these new types of harassment.

Help us improve resources for patients with rheumatic conditions! This is a brief, anonymous survey aimed to gather information about what additional resources you'd like to learn about from your rheumatology care team. Learning about your interest and priorities will inform future development of programs, resources, and tools to promote health.

This study is exploring whether the new drug combo of TNG462 + RMC‑6236/9805 can be safely given to patients with tough pancreatic or lung cancers that have specific genetic markers, and if it shows promising early signs of fighting the cancer.

Would you like to learn more about your body composition and resting metabolic rate? If you identify as Asian and are between 18-35 years old, you may be eligible to participate in a research study evaluating body composition and metabolic health in multiple Asian ethnicities.